Mechanisms of erosion of atherosclerotic plaques. Issue 5 (October 2017)

• Record Type: Journal Article
• Authors: Quillard, Thibaut; Franck, Grégory; Mawson, Thomas; Folco, Eduardo; Libby, Peter
• Is Part Of: Current opinion in lipidology. Volume 28:Issue 5(2017:Oct.)
• Publication Date: 2017-10
• Subjects: acute coronary syndromes -- glycosaminoglycans -- intimal hyperplasia -- lipid lowering therapy; Lipids -- Periodicals; 572.574
• DOI: 10.1097/MOL.0000000000000440
• Languages: English
• ISSNs: 1473-6535

Abstract

Abstract : Purpose of review: The present review explores the mechanisms of superficial intimal erosion, a common cause of thrombotic complications of atherosclerosis. Recent findings: Human coronary artery atheroma that give rise to thrombosis because of erosion differ diametrically from those associated with fibrous cap rupture. Eroded lesions characteristically contain few inflammatory cells, abundant extracellular matrix, and neutrophil extracellular traps (NETs). Innate immune mechanisms such as engagement of Toll-like receptor 2 (TLR2) on cultured endothelial cells can impair their viability, attachment, and ability to recover a wound. Hyaluronan fragments may serve as endogenous TLR2 ligands. Mouse experiments demonstrate that flow disturbance in arteries with neointimas tailored to resemble features of human eroded plaques disturbs endothelial cell barrier function, impairs endothelial cell viability, recruits neutrophils, and provokes endothelial cells desquamation, NET formation, and thrombosis in a TLR2-dependent manner. Summary: Mechanisms of erosion have received much less attention than those that provoke plaque rupture. Intensive statin treatment changes the characteristic of plaques that render them less susceptible to rupture. Thus, erosion may contribute importantly to the current residual burden of risk. Understanding the mechanisms of erosion may inform the development and deployment of novel therapies to combat the remaining atherothrombotic risk in the statin era.